Science:Life Sciences
How Effective Are Antibody Treatments For COVID-19?
2020-12-07
Download
Right click and do "save link as"
The FDA has issued emergency use authorizations for two monoclonal antibody treatments for COVID-19 – one produced by Eli Lilly and another by Regeneron. As science correspondent Richard Harris explains, emergency use authorization doesn't assure that these new drugs are effective, but that their potential benefits are likely to outweigh the risks. So today, we get to the bottom of how this type of treatment works and if they'll really make a difference.
Email the show your questions, coronavirus or otherwise, at shortwave@npr.org.
Learn more about sponsor message choices: podcastchoices.com/adchoices
NPR Privacy Policy
view more
Email the show your questions, coronavirus or otherwise, at shortwave@npr.org.
Learn more about sponsor message choices: podcastchoices.com/adchoices
NPR Privacy Policy
More Episodes
Tick Check! Meet Your Backyard Bloodsuckers
2023-07-05
2023-07-05
The Chemistry Behind A Perfect Barbeque
2023-07-03
2023-07-03
An unexpected forest in the ocean
2023-06-28
2023-06-28
A Smarter Way To Use Sunscreen
2023-06-26
2023-06-26
Rethinking The Lab Rat
2023-06-23
2023-06-23
This Satellite Could Help Clean Up The Air
2023-06-21
2023-06-21
New Star Trek Season, Same Ol' Sci-Fi
2023-06-19
2023-06-19
Give Rivers Space: The Simple Flood Risk Fix
2023-06-14
2023-06-14
Life Lessons From Supernovae
2023-06-12
2023-06-12
How To Stay Safe Amid Wildfire Smoke
2023-06-09
2023-06-09
Behold! The Dulcet Tones Of Cosmic Rays
2023-06-07
2023-06-07
The Rise Of The Dinosaurs
2023-06-05
2023-06-05
Helping A Man Walk Again With Science
2023-06-02
2023-06-02
When Your Body Rejects The Kidney It Needs
2023-05-24
2023-05-24
Two Squirrely Responses To Climate Change
2023-05-22
2023-05-22
Get this podcast on your
phone, FREE
